Predict your next investment

Immusoft company logo
Corporation
HEALTHCARE | Biotechnology
immusoft.com

See what CB Insights has to offer

Founded Year

2009

Stage

Grant - II | Alive

Total Raised

$36.83M

Last Raised

$470K | 1 yr ago

About Immusoft

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The first ISP-based treatment Immusoft will advance to human trials is a therapy for MPS I, a rare, genetic, lysosomal storage disease. ISP technology will be used to make patient's immune cells continually secrete a-L-iduronidase (IDUA).

Immusoft Headquarter Location

454 N 34th St.

Seattle, Washington, 98103,

United States

206-931-0262

Latest Immusoft News

Immusoft inks deal with Takeda on rare neurometabolic disorders

Oct 18, 2021

Seattle, USA-based cell therapy company Immusoft has signed a research collaboration and license option… To continue reading The Pharma Letter please login ,   subscribe  or  claim a 7 day free trial subscription  and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. Or, if you're only interested in reading the content about a specific topic (M&A, coronavirus/COVID-19, pricing, reimbursement and access, outsourcing, CRO and CMO, and regulation), then you can take our £10 per month channel subscription offer, which gives you access to all our news articles and in-depth content on this subject.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Immusoft

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Immusoft is included in 4 Expert Collections, including Smart Money VCs (2017-2019).

S

Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

P

Pharma Startups

11,639 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,880 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Immusoft Patents

Immusoft has filed 6 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Biotechnology
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/5/2018

8/31/2021

Molecular biology, Biotechnology, Genetics, Transcription factors, Clusters of differentiation

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/5/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/31/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, Biotechnology, Genetics, Transcription factors, Clusters of differentiation

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Immusoft Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Immusoft Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.